Literature DB >> 23438877

Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?

Rachel R J Kalf, Rachel Bakker, A Cecile J W Janssens.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23438877     DOI： 10.2217/pgs.13.8

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  2 in total

1.  Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events.

Authors:  Tamara P Miller; Brian T Fisher; Kelly D Getz; Leah Sack; Hanieh Razzaghi; Alix E Seif; Rochelle Bagatell; Peter C Adamson; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2019-04-09       Impact factor: 3.167

2.  Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies.

Authors:  E C M Tonk; D Gurwitz; A-H Maitland-van der Zee; A C J W Janssens
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.